I. D. S. Silva, A. Maclean, D. Mayer, P. Hardiman, G. Lieberman, J. Nieto, M. Parsons, K. Rolfe, J. Ginsburg
{"title":"卵巢刺激会增加患卵巢癌的风险吗","authors":"I. D. S. Silva, A. Maclean, D. Mayer, P. Hardiman, G. Lieberman, J. Nieto, M. Parsons, K. Rolfe, J. Ginsburg","doi":"10.1017/S0962279903001017","DOIUrl":null,"url":null,"abstract":"A pooled analysis of data from 12 US case–control studies conducted by the Collaborative Ovarian Cancer Group and including 2197 cases of invasive epithelial ovarian cancer showed no overall association between physician-diagnosed female infertility and ovarian cancer. 15 , 23 Three of the studies included in this pooled analysis collected information on use of fertility drugs. Infertile women who had used fertility treatment were at an increased risk of invasive epithelial ovarian cancer (relative risk (RR) = 2.8 ; 95% CI = 1.3, 6.1), and of borderline ovarian tumours (RR = 4.0 ; 95% CI = 1.1, 13.9) compared to women without a history of infertility. The risk for the smaller subgroup who never got pregnant was 27 times (95% CI = 2.3, 315.6) that of nulligravid women who did not report infertility, whereas the risk for those who took drugs but did achieve a pregnancy was not raised. The results generated a great deal of interest because of the potentially serious implications for the rapidly expanding assisted conception programmes throughout the world. 40 , 41 Several possible explanations could account for the association between failed infertility treatment and ovarian cancer. As with all case–control studies, there is a possibility that recall bias might have led to an overestimation of the magnitude of these associations. 42 Even if the observed association between infertility treatment and ovarian cancer risk were real, women may have taken drugs for longer periods and in greater doses because they had a certain type of infertility that predisposed them a priori to both infertility and ovarian cancer. This latter possibility","PeriodicalId":329551,"journal":{"name":"Reproductive Medicine Review","volume":"110 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2003-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Does ovarian stimulation increase the risk of ovarian cancer\",\"authors\":\"I. D. S. Silva, A. Maclean, D. Mayer, P. Hardiman, G. Lieberman, J. Nieto, M. Parsons, K. Rolfe, J. Ginsburg\",\"doi\":\"10.1017/S0962279903001017\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A pooled analysis of data from 12 US case–control studies conducted by the Collaborative Ovarian Cancer Group and including 2197 cases of invasive epithelial ovarian cancer showed no overall association between physician-diagnosed female infertility and ovarian cancer. 15 , 23 Three of the studies included in this pooled analysis collected information on use of fertility drugs. Infertile women who had used fertility treatment were at an increased risk of invasive epithelial ovarian cancer (relative risk (RR) = 2.8 ; 95% CI = 1.3, 6.1), and of borderline ovarian tumours (RR = 4.0 ; 95% CI = 1.1, 13.9) compared to women without a history of infertility. The risk for the smaller subgroup who never got pregnant was 27 times (95% CI = 2.3, 315.6) that of nulligravid women who did not report infertility, whereas the risk for those who took drugs but did achieve a pregnancy was not raised. The results generated a great deal of interest because of the potentially serious implications for the rapidly expanding assisted conception programmes throughout the world. 40 , 41 Several possible explanations could account for the association between failed infertility treatment and ovarian cancer. As with all case–control studies, there is a possibility that recall bias might have led to an overestimation of the magnitude of these associations. 42 Even if the observed association between infertility treatment and ovarian cancer risk were real, women may have taken drugs for longer periods and in greater doses because they had a certain type of infertility that predisposed them a priori to both infertility and ovarian cancer. This latter possibility\",\"PeriodicalId\":329551,\"journal\":{\"name\":\"Reproductive Medicine Review\",\"volume\":\"110 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2003-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reproductive Medicine Review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1017/S0962279903001017\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproductive Medicine Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/S0962279903001017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
摘要
一项由卵巢癌合作小组进行的12项美国病例对照研究(包括2197例侵袭性上皮性卵巢癌)的数据汇总分析显示,医生诊断的女性不孕症与卵巢癌之间没有总体关联。15,23本综合分析中包括的三项研究收集了关于使用生育药物的资料。接受过生育治疗的不孕妇女患侵袭性上皮性卵巢癌的风险增加(相对风险(RR) = 2.8;95% CI = 1.3, 6.1)和交界性卵巢肿瘤(RR = 4.0;95% CI = 1.1, 13.9),与无不孕史的女性相比。从未怀孕的小亚组的风险是未报告不孕的无妊娠妇女的27倍(95% CI = 2.3, 315.6),而服用药物但成功怀孕的妇女的风险没有增加。这些结果引起了极大的兴趣,因为它可能对全世界迅速扩大的辅助受孕方案产生严重影响。40,41几种可能的解释可以解释不孕不育治疗失败和卵巢癌之间的联系。与所有病例对照研究一样,回忆偏差可能导致高估了这些关联的大小。42 .即使观察到的不孕症治疗与卵巢癌风险之间的关联是真实的,妇女服用药物的时间更长,剂量更大,可能是因为她们患有某种不孕症,这种不孕症使她们先天易患不孕症和卵巢癌。后一种可能性
Does ovarian stimulation increase the risk of ovarian cancer
A pooled analysis of data from 12 US case–control studies conducted by the Collaborative Ovarian Cancer Group and including 2197 cases of invasive epithelial ovarian cancer showed no overall association between physician-diagnosed female infertility and ovarian cancer. 15 , 23 Three of the studies included in this pooled analysis collected information on use of fertility drugs. Infertile women who had used fertility treatment were at an increased risk of invasive epithelial ovarian cancer (relative risk (RR) = 2.8 ; 95% CI = 1.3, 6.1), and of borderline ovarian tumours (RR = 4.0 ; 95% CI = 1.1, 13.9) compared to women without a history of infertility. The risk for the smaller subgroup who never got pregnant was 27 times (95% CI = 2.3, 315.6) that of nulligravid women who did not report infertility, whereas the risk for those who took drugs but did achieve a pregnancy was not raised. The results generated a great deal of interest because of the potentially serious implications for the rapidly expanding assisted conception programmes throughout the world. 40 , 41 Several possible explanations could account for the association between failed infertility treatment and ovarian cancer. As with all case–control studies, there is a possibility that recall bias might have led to an overestimation of the magnitude of these associations. 42 Even if the observed association between infertility treatment and ovarian cancer risk were real, women may have taken drugs for longer periods and in greater doses because they had a certain type of infertility that predisposed them a priori to both infertility and ovarian cancer. This latter possibility